• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts.

作者信息

Heslop H E, Brenner M K, Rooney C, Krance R A, Roberts W M, Rochester R, Smith C A, Turner V, Sixbey J, Moen R

出版信息

Hum Gene Ther. 1994 Mar;5(3):381-97. doi: 10.1089/hum.1994.5.3-381.

DOI:10.1089/hum.1994.5.3-381
PMID:8018749
Abstract
摘要

相似文献

1
Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts.将新霉素抗性基因标记的EB病毒特异性细胞毒性T淋巴细胞给予不匹配相关或表型相似的无关供体骨髓移植受者。
Hum Gene Ther. 1994 Mar;5(3):381-97. doi: 10.1089/hum.1994.5.3-381.
2
Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease.生产用于过继转移至患EB病毒相关淋巴增殖性疾病高风险患者的转基因爱泼斯坦-巴尔病毒特异性细胞毒性T细胞。
J Hematother. 1995 Apr;4(2):73-9. doi: 10.1089/scd.1.1995.4.73.
3
Virus-specific cytotoxic T lymphocytes as prophylaxis for Epstein-Barr virus lymphoproliferative disease in pediatric bone marrow transplant recipients.病毒特异性细胞毒性T淋巴细胞用于预防儿童骨髓移植受者的EB病毒淋巴增殖性疾病
J Pediatr Oncol Nurs. 1997 Oct;14(4):194-201. doi: 10.1177/104345429701400403.
4
Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants.
Important Adv Oncol. 1996:149-66.
5
The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation.异基因骨髓移植后针对EB病毒的细胞免疫的发展
Blood. 1996 Mar 15;87(6):2594-603.
6
Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.输注供体白细胞以治疗异基因骨髓移植后与爱泼斯坦-巴尔病毒相关的淋巴增殖性疾病。
N Engl J Med. 1994 Apr 28;330(17):1185-91. doi: 10.1056/NEJM199404283301703.
7
Unsuccessful CTL transfusion in a case of post-BMT Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD).1例异基因造血干细胞移植后爱泼斯坦-巴尔病毒相关淋巴增殖性疾病（EBV-LPD）患者的细胞毒性T淋巴细胞输注失败。
Bone Marrow Transplant. 1997 Aug;20(4):337-40. doi: 10.1038/sj.bmt.1700883.
8
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation.使用基因修饰的病毒特异性T淋巴细胞来控制爱泼斯坦-巴尔病毒相关的淋巴增殖。
Lancet. 1995 Jan 7;345(8941):9-13. doi: 10.1016/s0140-6736(95)91150-2.
9
Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation.将单纯疱疹病毒胸苷激酶（HSV-tk）基因转入供体外周血淋巴细胞，用于异基因骨髓移植后对供体抗肿瘤免疫进行体内调节。
Hum Gene Ther. 1995 Jun;6(6):813-9. doi: 10.1089/hum.1995.6.6-813.
10
Assessment of the efficacy of purging by using gene marked autologous marrow transplantation for children with AML in first complete remission.采用基因标记自体骨髓移植对首次完全缓解的急性髓系白血病患儿进行清髓疗效评估。
Hum Gene Ther. 1994 Apr;5(4):481-99. doi: 10.1089/hum.1994.5.4-481.

引用本文的文献

1
Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects.T 细胞受体工程化 T 细胞治疗癌症：当前策略、挑战与展望。
Front Immunol. 2022 Mar 3;13:835762. doi: 10.3389/fimmu.2022.835762. eCollection 2022.
2
The Tumor Microenvironment in Post-Transplant Lymphoproliferative Disorders.移植后淋巴增殖性疾病中的肿瘤微环境
Cancer Microenviron. 2019 Apr;12(1):3-16. doi: 10.1007/s12307-018-00219-5. Epub 2019 Jan 24.
3
Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive Tumors.
基于4-1BB的过继性T细胞疗法治疗爱泼斯坦-巴尔病毒（EBV）阳性肿瘤的I期临床试验
J Immunother. 2016 Apr;39(3):140-8. doi: 10.1097/CJI.0000000000000113.
4
Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders.利用先天免疫和适应性免疫之间的相互作用，以改善针对爱泼斯坦-巴尔病毒驱动疾病的免疫治疗策略。
Clin Dev Immunol. 2012;2012:931952. doi: 10.1155/2012/931952. Epub 2012 Jan 29.
5
Targeting cytomegalovirus-infected cells using T cells armed with anti-CD3 × anti-CMV bispecific antibody.利用携带抗 CD3×抗 CMV 双特异性抗体的 T 细胞靶向巨细胞病毒感染的细胞。
Biol Blood Marrow Transplant. 2012 Jul;18(7):1012-22. doi: 10.1016/j.bbmt.2012.01.022. Epub 2012 Feb 5.
6
NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignancies.NCI 首次国际造血细胞移植后复发的生物学、预防和治疗专题研讨会：血液恶性肿瘤异基因细胞移植后预防复发专题委员会报告。
Biol Blood Marrow Transplant. 2010 Aug;16(8):1037-69. doi: 10.1016/j.bbmt.2010.05.005. Epub 2010 May 24.
7
Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex).使用透气快速扩增培养器（G-Rex）加速用于临床前和临床应用的抗原特异性 T 细胞的生产。
J Immunother. 2010 Apr;33(3):305-15. doi: 10.1097/CJI.0b013e3181c0c3cb.
8
Treatment of lymphoma with adoptively transferred T cells.采用过继性转移T细胞治疗淋巴瘤。
Expert Opin Biol Ther. 2009 Nov;9(11):1407-25. doi: 10.1517/14712590903260785.
9
The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation.造血干细胞移植中巨细胞病毒感染的防治
Cancer Immunol Immunother. 2009 Sep;58(9):1481-8. doi: 10.1007/s00262-009-0722-7. Epub 2009 May 23.
10
T cell immunotherapeutic populations control viral infections in bone marrow transplant recipients.T细胞免疫治疗群体可控制骨髓移植受者的病毒感染。
Immunol Res. 2001;24(3):289-301. doi: 10.1385/IR:24:3:289.